fosamprenavir has been researched along with Cancer of Esophagus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaine-Sauer, S; Johnston, N; Samuels, TL; Yan, K | 1 |
1 other study(ies) available for fosamprenavir and Cancer of Esophagus
| Article | Year |
|---|---|
The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes.
Topics: Animals; Enzyme Inhibitors; Esophageal Neoplasms; Laryngopharyngeal Reflux; Mice; Pepsin A; Protease Inhibitors; Proton Pump Inhibitors; Quality of Life | 2023 |